Showing results (1201-1210 of 5,984) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|September 24, 2020
Preclinical Development of MGC018, a Duocarmycin-based Antibody-drug Conjugate Targeting B7-H3 for Solid CancerJuniper A Scribner, Jennifer G Brown, Thomas Son, et al.
Molecular Cancer Therapeutics|December 3, 2020
Combinatorial Efficacy of Olaparib with Radiation and ATR Inhibitor Requires PARP1 Protein in Homologous Recombination-Proficient Pancreatic CancerLeslie A Parsels, Carl G Engelke, Joshua Parsels, et al.
Molecular Cancer Therapeutics|December 3, 2020
A Pilot Study of Galunisertib plus Stereotactic Body Radiotherapy in Patients with Advanced Hepatocellular CarcinomaKim A Reiss, Max M Wattenberg, Nevena Damjanov, et al.
Molecular Cancer Therapeutics|December 4, 2020
Development of Novel Antibody-Camptothecin ConjugatesRyan D Lyski, Lauren B Bou, Uland Y Lau, et al.
Molecular Cancer Therapeutics|December 5, 2020
Effects of MTX-23, a Novel PROTAC of Androgen Receptor Splice Variant-7 and Androgen Receptor, on CRPC Resistant to Second-Line Antiandrogen TherapyGeun Taek Lee, Naoya Nagaya, Jenny Desantis, et al.
Molecular Cancer Therapeutics|December 5, 2020
The Histone Methyltransferase Gene G9A Is Regulated by Nuclear Receptor 4A1 in Alveolar Rhabdomyosarcoma CellsRupesh Shrestha, Kumaravel Mohankumar, Un-Ho Jin, et al.
Molecular Cancer Therapeutics|December 10, 2020
HDP-101, an Anti-BCMA Antibody-Drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma CellsVianihuini Figueroa-Vazquez, Jonathan Ko, Christian Breunig, et al.
Molecular Cancer Therapeutics|December 11, 2020
Targeting PIM Kinases to Overcome Therapeutic Resistance in CancerRachel K Toth, Noel A Warfel
Molecular Cancer Therapeutics|October 13, 2022
Ubiquitinated PCNA Drives USP1 Synthetic Lethality in CancerAntoine Simoneau, Justin L Engel, Madhavi Bandi, et al.
Molecular Cancer Therapeutics|September 26, 2022
Sensitization to Ionizing Radiation by MEK Inhibition Is Dependent on SNAI2 in Fusion-Negative RhabdomyosarcomaNicole R Hensch, Kathryn Bondra, Long Wang, et al.
Pageof 599